Nonalcoholic fatty liver: Does it have tube biopsed?;Stéatose hépatique non alcoolique: Faut-il biopsier?

Revue Medicale Suisse

Volumn 1, Issue 43, 2005, Pages 2804-2808

  Rubbia Brandt, Laura ^a   Hadengue, Antoine ^b  

^a Service de pathologie clinique   (Switzerland)

^b HUG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; MEDICAL PRACTICE; MEDICAL SPECIALIST; MORBIDITY; NONALCOHOLIC FATTY LIVER; REVIEW; ARTICLE; BIOPSY; CHILD; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; PATHOLOGY; PATIENT SELECTION; RISK FACTOR;

BIOPSY; CHILD; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; HUMANS; PATIENT SELECTION; RISK FACTORS;

EID: 33644759406     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Marchesinin G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23.
2. Fassio E, et al. Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies. Hepatology 2004;40:820-6.
3. Harrison SA, et al. The natural history of non-alcoholic fatty liver disease. A clinicopathological study. Am J Gastroenterol 2003;98:1915-7.
4. Ratziu V, et al. Diagnostic value of biochemical markers (fibrotest) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver. Hepatology 2003;34: 510A.
5. Lainé F, et al. Prediction of fibrosis with patients with features of the metabolic syndrome, regardless of alcohol consumption. Hepatology 2004;39:1639-46.
6. Brunt E, et al. Nonalcoholic steatohepatitis: Histologic features and clinical correlations with 30 blinded specimens. Hum Pathol 2004;35:1070-82.
7. Neuschwander-Tetri BA, Caldwell SH. Non-alcoholic steatohepatitis. Summary of an AASLD single-topic conference. Hepatology 2003;37:1202-19.
8. Bugianesi E, et al. Relative contribution of iron burden, HFE mutations and insulin resistance to fibrosis in non-alcoholic fatty liver. Hepatology 2004;39:179-87.
9. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005;42:641-9.
10. Javor ED, et al. Leptin reverses non-alcoholic steatohepatitis in patients with severe lipodystrophy. Hepatology 2005;41:753-60.
11. Kerkar N. Non-alcoholic steatohepatitis in children. Pediatr Transpl 2004;8:613-8.
12. Promrat K, et al. A pilot study of pioglitazone treatment for non-alcoholic steatohepatitis. Hepatology 2004; 39:188-96.